NCT03392792

Brief Summary

• Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 8, 2018

Completed
12 months until next milestone

Study Start

First participant enrolled

December 30, 2018

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

January 8, 2018

Status Verified

January 1, 2018

Enrollment Period

Same day

First QC Date

December 14, 2017

Last Update Submit

January 4, 2018

Conditions

All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex

Outcome Measures

Primary Outcomes (1)

  • Registry of the stroke Patients in Assist University Hospital

    one year

Study Arms (2)

tissue plasmnogen activator

ACTIVE COMPARATOR
Drug: tissue plasminogen activator

thrombectoy

ACTIVE COMPARATOR
Procedure: thrombectomy

Interventions

tissue plasminogen activatorDRUG

role of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA

Also known as: rtpa
tissue plasmnogen activator
thrombectomyPROCEDURE

role of thrombectomy in patient with acute ischemic stroke

thrombectoy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with stroke aged ≥18 years of both sex
  • Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks

You may not qualify if:

  • Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
  • Stroke due to Brain tumors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Tissue Plasminogen ActivatorThrombectomy

Intervention Hierarchy (Ancestors)

Serine EndopeptidasesEndopeptidasesPeptide HydrolasesHydrolasesEnzymesEnzymes and CoenzymesSerine ProteasesPlasminogen ActivatorsBlood Coagulation FactorsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsBiological FactorsVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 14, 2017

First Posted

January 8, 2018

Study Start

December 30, 2018

Primary Completion

December 30, 2018

Study Completion

December 30, 2018

Last Updated

January 8, 2018

Record last verified: 2018-01